Sign in

CIK 0000886744

  • Large accelerated filer
Ticker
GERN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752287752
Phone
+1 650-473-7700
Business address
919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
Former names
GERON CORPORATION
Open-market buys, last 90 days
$62,105
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$62,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Semerjian Harout +$51K President & CEO 1 filing
  2. Williams Timothy +$11K EVP and Chief Legal Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-09 SCARLETT JOHN A Chairman, President and CEO Option exercise +446,666 $1.50 $670K 446,666
2023-02-09 SCARLETT JOHN A Chairman, President and CEO Sale −446,666 $3.03 $1.4M 0
2023-02-09 SCARLETT JOHN A Chairman, President and CEO Option exercise · Employee Stock Option (right to buy) −446,666 0
2023-02-08 Bloom Olivia Kyusuk EVP, Chief Financial Officer Option exercise +400,000 $1.51 $604K 474,588
2023-02-08 Bloom Olivia Kyusuk EVP, Chief Financial Officer Sale −400,000 $3.08 $1.2M 74,588
2023-02-08 Bloom Olivia Kyusuk EVP, Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −400,000 0
2023-02-08 SCARLETT JOHN A Chairman, President and CEO Option exercise +446,666 $1.50 $670K 446,666
2023-02-08 SCARLETT JOHN A Chairman, President and CEO Sale −446,666 $3.08 $1.4M 0
2023-02-08 SCARLETT JOHN A Chairman, President and CEO Option exercise · Employee Stock Option (right to buy) −446,666 0
2023-01-13 EASTHAM KARIN Director Option exercise +35,000 $1.10 $39K 109,047
2023-01-13 EASTHAM KARIN Director Option exercise · Stock Options (right to buy) −35,000 0
2022-12-30 Kapur Anil EVP, Corp Strategy & CCO Grant or award +6,021 $1.11 $7K 53,216
2022-12-30 Spiegel Robert J. Director Grant or award +2,970 151,693
2022-09-30 Spiegel Robert J. Director Grant or award +3,071 148,723
2022-09-12 GRETHLEIN ANDREW J EVP, Chief Operating Officer Option exercise +2,000 $1.70 $3K 2,000
2022-09-12 GRETHLEIN ANDREW J EVP, Chief Operating Officer Option exercise +232,719 $1.70 $396K 234,719
2022-09-12 GRETHLEIN ANDREW J EVP, Chief Operating Officer Option exercise · Employee Stock Option (right to buy) −2,000 65,281
2022-09-12 GRETHLEIN ANDREW J EVP, Chief Operating Officer Option exercise · Employee Stock Option (right to buy) −232,719 0
2022-09-07 McDonald John F Director Grant or award · Stock Options (right to buy) +200,000 200,000
2022-07-08 Feller Faye EVP, Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +120,000 120,000

Page 8 of 15 · 291 trades